Global pattern of persistent human papillomavirus infection in female genital tract: An update system review and meta-analysis

被引：2

作者：

Zhao, Ming ^{[1
,3
]}

Kang, Peipei ^{[2
]}

Zhu, Liling ^{[3
]}

Zhou, Dan ^{[1
,3
]}

Cui, Meimei ^{[1
,4
]}

Zhang, Min ^{[3
]}

Jia, Jingjing ^{[5
]}

Luo, Limei ^{[6
]}

机构：

[1] Qingdao Univ, Shandong Prov Maternal & Child Hlth Care Hosp, Maternal & Child Hlth Dev Res Ctr, Jinan, Peoples R China

[2] Shandong Univ, Shandong Mental Hlth Ctr, Jinan, Peoples R China

[3] Jiamusi Univ, Sch Publ Hlth, Jiamusi, Peoples R China

[4] Weifang Med Coll, Sch Basic Med, Weifang, Peoples R China

[5] Jiamusi Univ, Sch Basic Med, Jiamusi, Peoples R China

[6] Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defect Surveillance China, Natl Off Maternal & Child Hlth Surveillance China,, Chengdu, Peoples R China

来源：

ISCIENCE | 2024年 / 27卷 / 10期

关键词：

CERVICAL HUMAN-PAPILLOMAVIRUS; EPIDEMIOLOGIC CLASSIFICATION; GENOTYPE DISTRIBUTION; NATURAL-HISTORY; HPV TYPES; WOMEN; PREVALENCE; RISK; CANCER; CLEARANCE;

D O I：

10.1016/j.isci.2024.110991

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

We analyzed the type-specific persistent infection of high-risk human papillomavirus (HR-HPV) across different continents, aiming to offer valuable insights into the implementation and development of HPV vaccines. There were 129 studies included 656,555 participants. The weighted mean time for any persistent HPV infection was 13.29 months. The single and multiple HPV infection were persistent for median of 12.27 and 18.99 months, respectively. HPV35 is the common genotype of persistent infection in Asia and Africa, as well as HPV53 in Europe. Individuals (>50 years old) were to be more prone to persistent infection. Our study revealed approximately 50% of persistent HPV infection resolved after two years. A 24-month interval for HPV testing is proposed as a way to identify persistent HPV infection. In addition, to develop region-specific guidelines for HPV vaccines can be utilized as references for the diagnosis and treatment of cervical cancer.

引用

页数：13

共 74 条

[1] Are 20 human papillomavirus types causing cervical cancer? [J].

Arbyn, Marc ;

Tommasino, Massimo ;

Depuydt, Christophe ;

Dillner, Joakim .

JOURNAL OF PATHOLOGY, 2014, 234 (04) :431-435

[2] Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: A prospective study in Uganda [J].

Banura C. ;

Sandin S. ;

Van Doorn L.-J. ;

Quint W. ;

Kleter B. ;

Wabwire-Mangen F. ;

Mbidde E.K. ;

Weiderpass E. .

Infectious Agents and Cancer, 5 (1)

[3] Meta-analysis of prevalence [J].

Barendregt, Jan J. ;

Doi, Suhail A. ;

Lee, Yong Yi ;

Norman, Rosana E. ;

Vos, Theo .

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2013, 67 (11) :974-978

[4] A meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination [J].

Bhatla, Neerja ;

Lal, Neena ;

Bao, Yan-Ping ;

Ng, Timothy ;

Qiao, You-Lin .

VACCINE, 2008, 26 (23) :2811-2817

[5] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].

BOSCH, FX ;

MANOS, MM ;

MUNOZ, N ;

SHERMAN, M ;

JANSEN, AM ;

PETO, J ;

SCHIFFMAN, MH ;

MORENO, V ;

KURMAN, R ;

SHAH, KV ;

ALIHONOU, E ;

BAYO, S ;

MOKHTAR, HC ;

CHICAREON, S ;

DAUDT, A ;

DELOSRIOS, E ;

GHADIRIAN, P ;

KITINYA, JN ;

KOULIBALY, M ;

NGELANGEL, C ;

TINTORE, LMP ;

RIOSDALENZ, JL ;

SARJADI ;

SCHNEIDER, A ;

TAFUR, L ;

TEYSSIE, AR ;

ROLON, PA ;

TORROELLA, M ;

TAPIA, AV ;

WABINGA, HR ;

ZATONSKI, W ;

SYLLA, B ;

VIZCAINO, P ;

MAGNIN, D ;

KALDOR, J ;

GREER, C ;

WHEELER, C .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802

[6] Determinants of persistent detection of human papillomavirus DNA in the uterine cervix [J].

Brisson, J ;

Bairati, I ;

Morin, C ;

Fortier, M ;

Bouchard, C ;

Christen, A ;

Bernard, P ;

Roy, M ;

Meisels, A .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) :794-799

[7] Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings [J].

Bruni, Laia ;

Diaz, Mireia ;

Castellsague, Xavier ;

Ferrer, Elena ;

Bosch, F. Xavier ;

de Sanjose, Silvia .

JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (12) :1789-1799

[8] High-risk HPV type-specific clearance rates in cervical screening [J].

Bulkmans, N. W. J. ;

Berkhof, J. ;

Bulk, S. ;

Bleeker, M. C. G. ;

van Kemenade, F. J. ;

Rozendaal, L. ;

Snijders, P. J. F. ;

Meijer, C. J. L. M. .

BRITISH JOURNAL OF CANCER, 2007, 96 (09) :1419-1424

[9] Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities [J].

Castle, PE ;

Solomon, D ;

Schiffman, M ;

Wheeler, CM .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (14) :1066-1071

[10] Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide [J].

Chan, Paul K. S. ;

Ho, Wendy C. S. ;

Chan, Martin C. W. ;

Wong, Martin C. S. ;

Yeung, Apple C. M. ;

Chor, Josette S. Y. ;

Hui, Mamie .

PLOS ONE, 2014, 9 (09)

← 1 2 3 4 5 6 7 8 →